Artius II Acquisition Inc. (AACB)

NASDAQ: AACB · Real-Time Price · USD

10.31

0.00 (0.00%)

Aug 7, 2025, 4:00 PM - Market closed

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Selling, General & Admin	0.2
Operating Expenses	0.2
Operating Income	-0.2
Pretax Income	-0.2
Net Income	-0.2
Net Income to Common	-0.2
Shares Outstanding (Basic)	5
Shares Outstanding (Diluted)	5
EPS (Basic)	-0.04
EPS (Diluted)	-0.04
EBIT	-0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q